Trials / Completed
CompletedNCT02988739
Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine
Safety and Immunogenicity of Laser Assisted Epidermally Administered Seasonal Influenza Vaccine in Comparison to Intradermally Administered Seasonal Influenza Vaccine
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Pantec Biosolutions AG · Industry
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
It is the aim of the present study to compare the immunogenicity induced by a laser-assisted epidermally administered seasonal influenza vaccine to an intradermally administered seasonal influenza vaccine.
Detailed description
The skin is an attractive tissue for vaccination due to the impact of the cutaneous micro-environment on the adaptive and non-adaptive immune responses. Conventionally many vaccines are administered subcutaneously. Immune-competent cells however are not resident in the subcutaneous fat tissue, but instead are located in the epidermis and the dermis of the skin. Depending on the targeted skin layer and administration method, different immunological outcomes are thus anticipated following vaccination. In the present study, the immunogenicity (in terms of activation of B-cell mediated and T-cell mediated immune responses) of laser-assisted epidermally administered seasonal influenza vaccine will be compared to needle-based intradermal administration of the same seasonal influenza vaccine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | seasonal influenza vaccine | influenza vaccine containing 15 µg haemagglutinin of three seasonal influenza virus strains recommended by WHO |
| DEVICE | fractional Er:Yag laser | Fraction laser device to apply micorpores of defined depth and density into skin. |
Timeline
- Start date
- 2017-02-22
- Primary completion
- 2017-07-31
- Completion
- 2017-09-30
- First posted
- 2016-12-09
- Last updated
- 2018-03-06
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT02988739. Inclusion in this directory is not an endorsement.